TABLE 1.
Groupa | No. of sequences
|
||
---|---|---|---|
Embryo (n = 92) | Newborn (n = 57) | Adult (n = 25) | |
P-Sp/AGM | 20 | ||
Liver | 29 | 39 | |
YS | 33 | ||
Blood | 10 | ||
Spleen | 18 | 25 | |
E10/11/12 | 24/50/18 | ||
DFL16b | 28 | 45 | 7 |
DSP2 | 64 | 12 | 18 |
JH1 | 10 | 15 | 0 |
JH2 | 21 | 14 | 0 |
JH3 | 28 | 12 | 2 |
JH4 | 33 | 16 | 23 |
ORF1 | 40 | 36 | 14 |
ORF2 | 23 | 8 | 2 |
ORF3 | 29 | 13 | 9 |
P-Sp/AGM, para-aortic splanchnopleura/aorta-gonad-mesonephros region; YS, yolk sac.
Two embryo DJH sequences and one adult DJH sequence used the DFL16.2 gene and were not included in the experimental analyses. The DFL16/DSP2 ratios were as follows: embryo, 0.36; newborn, 3.75; adult, 0.39.